Catherine Doherty, principal, Investit
OTC derivatives will continue to dominate the buy side's operational and technological priorities. Investment managers and outsourcers are developing long-term plans to support OTCs – firms are currently formalising OTC governance procedures. They are also prioritising OTC pricing and valuation data, collateral management and improved IT solutions to handle OTC complexity.
The MiFID requirement for best execution of OTCs will create a vigorous debate on i
Anthony and James talk AI and ESG, Reg SCI and the SEC, and Game of Thrones and Dragons.Subscribe to Weekly Wrap emails